Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.0700
+0.0050 (7.69%)
Aug 15, 2025, 3:28 PM EDT
Britannia Life Sciences Revenue
In the fiscal year ending March 31, 2025, Britannia Life Sciences had annual revenue of 369.28K CAD, down -28.55%.
Revenue
369.28K
Revenue Growth
-28.55%
P/S Ratio
30.76
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 929.68M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 1.10B |
| Extendicare | 1.51B |